# Eli Lilly on Site Enablement: Co-Designing Solutions with Sites

Page: https://stenobird.com/podcast/pharmatalkradio-7131046/eli-lilly-on-site-enablement-co-designing-solutions-with-sites
Text version: https://stenobird.com/podcast/pharmatalkradio-7131046/eli-lilly-on-site-enablement-co-designing-solutions-with-sites.md
Podcast: [PharmaTalkRadio](https://stenobird.com/podcast/pharmatalkradio-7131046)
Published: 2026-05-08T16:14:16+00:00
Episode link: https://www.spreaker.com/episode/eli-lilly-on-site-enablement-co-designing-solutions-with-sites--71926159
Audio file: https://dts.podtrac.com/redirect.mp3/api.spreaker.com/download/episode/71926159/eli_lilly_on_site_enablement_co_designing_solutions_with_sites.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/eli-lilly-on-site-enablement-co-designing-solutions-with-sites
Duration seconds: 2590

## Resource

A case study highlighting how Eli Lilly partnered with clinical sites to co-design practical, site-centric solutions that enhanced trial execution and operational efficiency. Fireside Guest: Shafaat Ali Khan Clinical Research Lead (CRL) Director – Investigator Engagement, Eli Lilly & Co Moderator: Jyoti Angal, PhD Director, Clinical Research, Avera McKennan Hospital & University Health Center

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/pharmatalkradio-7131046/episodes/eli-lilly-on-site-enablement-co-designing-solutions-with-sites/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/pharmatalkradio-7131046/eli-lilly-on-site-enablement-co-designing-solutions-with-sites.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.